These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26452319)

  • 41. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor.
    Zager A; Mennecier G; Palermo-Neto J
    Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
    Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
    Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of perinatal methylphenidate (MPH) treatment on postweaning behaviors of male and female Sprague-Dawley rats.
    Ferguson SA; Delbert Law C; Sahin L; Montenegro SV
    Neurotoxicol Teratol; 2015; 47():125-36. PubMed ID: 25514582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent exposure to aluminum and stress during pregnancy in rats: Effects on postnatal development and behavior of the offspring.
    Colomina MT; Roig JL; Torrente M; Vicens P; Domingo JL
    Neurotoxicol Teratol; 2005; 27(4):565-74. PubMed ID: 16024221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).
    Gizer IR; Waldman ID
    J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paternal nicotine exposure induces hyperactivity in next-generation via down-regulating the expression of DAT.
    Zhang M; Zhang D; Dai J; Cao Y; Xu W; He G; Wang Z; Wang L; Li R; Qiao Z
    Toxicology; 2020 Feb; 431():152367. PubMed ID: 31945395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
    Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
    Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.
    Hara Y; Takuma K; Takano E; Katashiba K; Taruta A; Higashino K; Hashimoto H; Ago Y; Matsuda T
    Behav Brain Res; 2015 Aug; 289():39-47. PubMed ID: 25907743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.
    Fan X; Hess EJ
    Neurobiol Dis; 2007 Apr; 26(1):201-11. PubMed ID: 17291774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Locomotor hyperactivity following prenatal exposure to 5-bromo-2'-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations.
    Kuwagata M; Muneoka KT; Ogawa T; Takigawa M; Nagao T
    Toxicol Lett; 2004 Aug; 152(1):63-71. PubMed ID: 15294348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):623-37. PubMed ID: 14624807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurobehavioral effects of prenatal exposure to AZT: a preliminary investigation with the D1 receptor agonist SKF 38393 in mice.
    Venerosi A; Valanzano A; Puopolo M; Calamandrei G
    Neurotoxicol Teratol; 2005; 27(1):169-73. PubMed ID: 15681130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice.
    Davis GL; Stewart A; Stanwood GD; Gowrishankar R; Hahn MK; Blakely RD
    Behav Brain Res; 2018 Jan; 337():61-69. PubMed ID: 28964912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral teratogenicity induced by nonforced maternal nicotine consumption.
    Paz R; Barsness B; Martenson T; Tanner D; Allan AM
    Neuropsychopharmacology; 2007 Mar; 32(3):693-9. PubMed ID: 16554741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.